Citigroup 6.875% Series K Preferred Stock
C.PRK
C.PRK was delisted on the 14th of November, 2023.
6 hedge funds and large institutions have $5.97M invested in Citigroup 6.875% Series K Preferred Stock in 2017 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 3 closing their positions.
33% less funds holding
Funds holding: 9 → 6 (-3)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $1.17M
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IR
IAT Reinsurance
New York
|
-$547K |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$246K |
| 3 |
Edge Wealth Management
New York
|
-$197K |
| 4 |
Parametric Portfolio Associates
Seattle,
Washington
|
-$117K |
| 5 |
Everett Harris & Co
Los Angeles,
California
|
-$37.1K |
C.PRK Hedge Fund Activity: Q1 2017 in Review
6 of the 4,036 institutional investors tracked by Wall St. Rank reported a position in Citigroup 6.875% Series K Preferred Stock (C.PRK) for Q1 2017, worth a combined $5.97M — down 14% from $6.93M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of C.PRK and 0 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 0 added.
The largest seller was IAT Reinsurance, exiting entirely with an estimated $547K sold.
- 6 institutional investors held Citigroup 6.875% Series K Preferred Stock (C.PRK) as of Q1 2017, down from 9 in Q4 2016.
- Funds reported $5.97M of Citigroup 6.875% Series K Preferred Stock stock for Q1 2017, down 14% quarter-over-quarter.
- 0 funds opened new Citigroup 6.875% Series K Preferred Stock positions in Q1 2017 and 3 closed out, a net change of -3 holders.
- The largest Citigroup 6.875% Series K Preferred Stock seller in Q1 2017 was IAT Reinsurance, an estimated $547K sold.
Based on aggregated 13F filings for Q1 2017.